KPTI ▼ -9.8% - Karyopharm Therapeutics Inc.
$KPTI KPTI - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm Therapeutics fell 9.8% today following the company's announcement of inducement grants under Nasdaq listing rules, which typically involve the issuance of new equity to employees and may signal dilution concerns to investors.
01-SEP-2026 04:06 PM ET
Share this post
More filings for $KPTI
KPTI ▲ +4.8% - Karyopharm Therapeutics Inc.Aug 31, 2026KPTI - Karyopharm Therapeutics Inc. Common Stock - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 15, 2026KPTI - Karyopharm Therapeutics Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026KPTI - Karyopharm Therapeutics Inc. - SEC Filing Update (11-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026$KPTI SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 28, 2026
💬 Comments
Loading comments…
Leave a comment
